Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response
- 1 October 2006
- journal article
- case report
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 55 (10) , 1425-1433
- https://doi.org/10.1099/jmm.0.46466-0
Abstract
Inquilinus limosus is a novel Gram-negative bacterium of the subdivision α-Proteobacteria recently found in the airways of patients with cystic fibrosis (CF). Here, the authors report on the clinical courses of six CF patients colonized with I. limosus. Five patients suffered from either an acute respiratory exacerbation or a progressive loss of pulmonary function, whereas one patient was in a stable clinical situation. This study focused on two aims: (i) the clonal analysis of I. limosus isolates by random amplified polymorphic DNA (RAPD)-PCR, and (ii) the clarification of whether the presence of I. limosus in the respiratory tract is associated with a specific serum antibody response. Serum IgG was detected by immunoblotting using I. limosus whole-cell-lysate proteins as antigens. Sera from healthy blood donors (n=10) and from CF patients colonized with Pseudomonas aeruginosa (n=10) were found to be immunoblot negative. All six Inquilinus-positive patients raised serum IgG antibodies against various I. limosus antigens. Surprisingly, in one patient, a specific I. limosus serum antibody response was already detected 1 year prior to Inquilinus-positive sputum cultures. Two prominent antigens were characterized by MALDI-MS: a 23 kDa protein revealed homology to the outer membrane lipoprotein OmlA of Actinobacillus pleuropneumoniae, and an 18 kDa protein to a protein-tyrosine phosphatase of Burkholderia cepacia. In conclusion, detection of I. limosus is accompanied by a specific serum antibody response and may reflect the infectious/pathogenic potential of I. limosus. Moreover, IgG immunoblotting may be useful to detect early infection with I. limosus and may support the selective cultivation of this novel emerging pathogen.Keywords
This publication has 22 references indexed in Scilit:
- Clinical and Microbiological Features ofInquilinussp. Isolates from Five Patients with Cystic FibrosisJournal of Clinical Microbiology, 2005
- Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: A marker of therapeutic success?—A 30‐year Cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infectionPediatric Pulmonology, 2004
- Infection byRalstoniaSpecies in Cystic Fibrosis Patients: Identification ofR. pickettiiandR. mannitolilyticaby Polymerase Chain ReactionEmerging Infectious Diseases, 2002
- Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. novJournal of Clinical Microbiology, 2002
- Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosisThorax, 2001
- Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical featuresCurrent Opinion in Pulmonary Medicine, 2000
- Antibody Response to Burkholderia cepacia in Patients with Cystic Fibrosis Colonized with Burkholderia cepacia and Pseudomonas aeruginosaJournal of Infection, 2000
- Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United StatesClinical Infectious Diseases, 1998
- Microbiology of airway disease in patients with cystic fibrosisClinical Microbiology Reviews, 1991
- Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosisPediatric Pulmonology, 1991